- Home
- JAGU vs PAVM Comparison
JAGU vs PAVM Comparison
Compare JAGU & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JAGU | PAVM |
|---|---|---|
| Founded | 2022 | 2014 |
| Country | Canada | United States |
| Employees | 3 | 41 |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.0M | 57.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JAGU | PAVM |
|---|---|---|
| Price | $2.72 | $9.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $65.00 |
| AVG Volume (30 Days) | ★ 492.3K | 9.8K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $603.94 |
| Revenue Next Year | N/A | $33.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.44 | $0.21 |
| 52 Week High | $3.60 | $28.44 |
Technical Indicators
Market Signals| Indicator | JAGU | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 53.89 | 44.69 |
| Support Level | $2.14 | $9.05 |
| Resistance Level | $2.94 | $9.26 |
| Average True Range (ATR) | 0.44 | 0.37 |
| MACD | 0.08 | -0.05 |
| Stochastic Oscillator | 46.83 | 8.40 |
Price Performance
Historical ComparisonAbout JAGU Jaguar Uranium Corp. Class A Common Shares
Jaguar Uranium Corp is a uranium exploration and development company focused on uranium discoveries. The company is a junior miner engaged in uranium exploration. Its portfolio is comprised of two uranium exploration projects in Argentina and one uranium exploration project in Colombia. Its projects include the Berlin Project, the Laguna Project, and the Huemul Project. The company operates in one reportable segment which is the exploration and evaluation of mineral properties.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.